Literature DB >> 27694171

11C- or 18F-Choline PET/CT for Imaging Evaluation of Biochemical Recurrence of Prostate Cancer.

Paola Mapelli1, Elena Incerti1, Francesco Ceci2, Paolo Castellucci2, Stefano Fanti2, Maria Picchio3.   

Abstract

Recurrence of prostate cancer is suspected when an increase in the prostate-specific antigen level is detected after radical treatment; the recurrence could be local relapse, distant relapse, or both. Differentiation between the two patterns of relapse is critical for choosing the proper treatment strategy. Choline PET/CT could be of help in discriminating patients with local, lymph node, and bone recurrences, thus having an impact on patient management.
© 2016 by the Society of Nuclear Medicine and Molecular Imaging, Inc.

Entities:  

Keywords:  11C-choline; 18F-choline; PET/CT; biochemical recurrence; prostate cancer

Mesh：

Substances：

Year:  2016        PMID： 27694171     DOI： 10.2967/jnumed.115.169755

Source DB:  PubMed          Journal:  J Nucl Med        ISSN： 0161-5505            Impact factor:   10.057


  14 in total

1.  Radiomics analysis of 18F-Choline PET/CT in the prediction of disease outcome in high-risk prostate cancer: an explorative study on machine learning feature classification in 94 patients.

Authors:  Pierpaolo Alongi; Alessandro Stefano; Albert Comelli; Riccardo Laudicella; Salvatore Scalisi; Giuseppe Arnone; Stefano Barone; Massimiliano Spada; Pierpaolo Purpura; Tommaso Vincenzo Bartolotta; Massimo Midiri; Roberto Lagalla; Giorgio Russo
Journal:  Eur Radiol       Date:  2021-01-14       Impact factor: 5.315

Review 2.  PET and PET/CT with radiolabeled choline in prostate cancer: a critical reappraisal of 20 years of clinical studies.

Authors:  Giampiero Giovacchini; Elisabetta Giovannini; Rossella Leoncini; Mattia Riondato; Andrea Ciarmiello
Journal:  Eur J Nucl Med Mol Imaging       Date:  2017-04-14       Impact factor: 9.236

3.  11C-choline PET/CT predicts survival in prostate cancer patients with PSA < 1 NG/ml.

Authors:  Giampiero Giovacchini; Priscilla Guglielmo; Paola Mapelli; Elena Incerti; Ana Maria Samanes Gajate; Elisabetta Giovannini; Mattia Riondato; Alberto Briganti; Luigi Gianolli; Andrea Ciarmiello; Maria Picchio
Journal:  Eur J Nucl Med Mol Imaging       Date:  2019-01-10       Impact factor: 9.236

4.  Fast indirect fluorine-18 labeling of protein/peptide using the useful 6-fluoronicotinic acid-2,3,5,6-tetrafluorophenyl prosthetic group: A method comparable to direct fluorination.

Authors:  Falguni Basuli; Xiang Zhang; Carolyn C Woodroofe; Elaine M Jagoda; Peter L Choyke; Rolf E Swenson
Journal:  J Labelled Comp Radiopharm       Date:  2017-02-01       Impact factor: 1.921

5.  Diagnostic performance of 18F-choline PET-CT in prostate cancer.

Authors:  P Samper Ots; A Luis Cardo; C Vallejo Ocaña; M A Cabeza Rodríguez; L A Glaria Enríquez; M L Couselo Paniagua; J Olivera Vegas
Journal:  Clin Transl Oncol       Date:  2018-11-17       Impact factor: 3.405

6.  Evaluation of tumor recurrences after radical prostatectomy using 18F-Choline PET/CT and 3T multiparametric MRI without endorectal coil: a single center experience.

Authors:  Felipe Couñago; Manuel Recio; Antonio Maldonado; Elia Del Cerro; Ana Aurora Díaz-Gavela; Israel J Thuissard; David Sanz-Rosa; Francisco José Marcos; Karmele Olaciregui; María Mateo; Laura Cerezo
Journal:  Cancer Imaging       Date:  2016-12-07       Impact factor: 3.909

7.  PET Tracer 18F-Fluciclovine Can Detect Histologically Proven Bone Metastatic Lesions: A Preclinical Study in Rat Osteolytic and Osteoblastic Bone Metastasis Models.

Authors:  Shuntaro Oka; Masaru Kanagawa; Yoshihiro Doi; David M Schuster; Mark M Goodman; Hirokatsu Yoshimura
Journal:  Theranostics       Date:  2017-05-15       Impact factor: 11.556

8.  The positivity rate of 68Gallium-PSMA-11 ligand PET/CT depends on the serum PSA-value in patients with biochemical recurrence of prostate cancer.

Authors:  Manuela A Hoffmann; Hans-Georg Buchholz; Helmut J Wieler; Thomas Höfner; Jonas Müller-Hübenthal; Ludwin Trampert; Mathias Schreckenberger
Journal:  Oncotarget       Date:  2019-10-22

Review 9.  Salvage therapy for prostate cancer after radical prostatectomy.

Authors:  Nicholas G Zaorsky; Jeremie Calais; Stefano Fanti; Derya Tilki; Tanya Dorff; Daniel E Spratt; Amar U Kishan
Journal:  Nat Rev Urol       Date:  2021-08-06       Impact factor: 14.432

10.  Evaluation of block-sequential regularized expectation maximization reconstruction of 68Ga-DOTATOC, 18F-fluoride, and 11C-acetate whole-body examinations acquired on a digital time-of-flight PET/CT scanner.

Authors:  Elin Lindström; Lars Lindsjö; Anders Sundin; Jens Sörensen; Mark Lubberink
Journal:  EJNMMI Phys       Date:  2020-06-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.